SEC Form 4 · accession 0001479791-18-000015
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Feb 20, 2018 | S | 100 | $0.1114 | D | 25,421,086 | D | |
| INVO Bioscience Common Stock | Feb 20, 2018 | S | 23,260 | $0.11 | D | 25,397,826 | D | |
| INVO Bioscience Common Stock | Feb 20, 2018 | S | 25,000 | $0.108 | D | 25,372,826 | D | |
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 28,662 | $0.1114 | D | 25,344,164 | D | |
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 10,000 | $0.112 | D | 25,334,164 | D | |
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 5,000 | $0.114 | D | 25,329,164 | D | |
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 17,900 | $0.12 | D | 25,311,264 | D | |
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 12,400 | $0.12 | D | 25,298,864 | D |
Table II — derivative securities
No Table II lines on this filing.